Oxford of 64 patients with SLE (61 female, three male) 10 women were found who had also suffered clinical thyroid disease. Seven had had thyrotoxicosis, predating the diagnosis of SLE in six by one to 17 years. All were treated with either carbimazole or Neo-Mercazole, and two required radiolabelled iodine for subsequent flares. Three patients had suffered hypothyroidism, predating the SLE in one, and were treated with thyroxine. Thyroid antibody levels were not available. The prevalence of overt thyroid disease in our group was 11-5% for thyrotoxicosis and 4-9% for hypothyroidism in women, compared with 1-9 and 1-0% respectively for a British population.2 There were no clinical features of this subgroup which distinguished them from the total SLE population. Goh and Wang suggest a possible association between the antibodies responsible for the false positive Wassermann reaction and the presence of thyroid disease. None of our thyroid subgroup had a false positive Wassermann reaction, and the frequency of anticardiolipin antibody was no different in these patients from that in the total group. It is possible that the thyroid disorders were related to the presence of thyroid stimulating and inhibiting immunoglobulins which have been demonstrated in patients with SLE.3 Two patients showed a third autoimmune disorder; pernicious anaemia in one and Addison's disease in the other. Among the SLE patients without overt thyroid disease were one with insulin dependent diabetes mellitus and one with myasthenia gravis, predating the SLE by 10 and eight years respectively. Clearly there is considerable overlap between the organ specific and non-organ specific autoimmune disorders.
Ankylosing spondylitis and middle ear impairment SIR, The publication in your journal of a case report by Magaro et al, in which a middle ear conductive impairment was observed in association with ankylosing spondylitis (AS),' drew our attention to the subject. We 
